Judicious 发表于 2025-3-23 12:04:50

http://reply.papertrans.cn/1/48/4788/4788-11.png

飞镖 发表于 2025-3-23 14:38:54

http://reply.papertrans.cn/1/48/4788/4788-12.png

阻止 发表于 2025-3-23 21:40:08

Submitted on: 02 June 2019.
Revised on: 20 September 2019.
Accepted on: 13 November 2019.

___________________Cardiovascular Therapeutics---WILEY-HINDAWI

Observe 发表于 2025-3-24 01:42:20

Submitted on: 28 May 2015.
Revised on: 18 July 2015.
Accepted on: 27 August 2015.

___________________Cardiovascular Therapeutics---WILEY-HINDAWI

提名 发表于 2025-3-24 04:41:42

http://reply.papertrans.cn/1/48/4788/4788-15.png

Endearing 发表于 2025-3-24 09:40:43

Submitted on: 23 January 2014.
Revised on: 10 April 2014.
Accepted on: 31 May 2014.

___________________Cardiovascular Therapeutics---WILEY-HINDAWI

反话 发表于 2025-3-24 11:53:27

Submitted on: 07 March 2022.
Revised on: 27 May 2022.
Accepted on: 08 July 2022.

___________________Cardiovascular Therapeutics---WILEY-HINDAWI

行为 发表于 2025-3-24 17:28:37

http://reply.papertrans.cn/1/48/4788/4788-18.png

现存 发表于 2025-3-24 20:27:43

http://reply.papertrans.cn/1/48/4788/4788-19.png

DOSE 发表于 2025-3-24 23:26:49

http://reply.papertrans.cn/1/48/4788/4788-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊Cardiovascular Therapeutics 2024/2025影响因子:3.404 (CARDIOVASC THER) (1755-5914). (CARDIAC & CARDIOVASCULAR SYSTEMS)